Article on NICHIGLUCAN was published in Agriculture and Food magazine from Italy
30/4/2021
“NICHIGLUCAN- potentials and clinical studies published in “Agro FOOD Industry- Hi tech”, an Italian magazine.
News
13 years of basic research data of GN Corporation published in paper
6/4/2021
GN Corporation published 13 years of basic research data in The Tokai Journal of Experimental and Clinical Medicine.
Bio Europe Spring 2021へ参加
18/2/2021
GN Corporation is participating in Bio Europe Spring 2021.
Nichi Glucan has been published in NutraIngredients-Asia
18/2/2021
Our product, Nichi glucan, has been published in N…
GN Corporation was featured in Eurobiz Japan
3/2/2021
GN Corporation was featured in a business magazine as one of the companies with sustainable production.
Initiation of joint research with Oakyama University
5/1/2021
Dr. Senthil Kumar Rajappa, whose arrival in Japan …
Biotech Showcase 2021
5/1/2021
GN Corporation is participating in Biotech Showcase 2021.
A paper on the potential of Nichi Glucan to prevent complications of coronavirus infection has been published in a journal.
28/10/2020
It argues that Nichiglucan may prevent complications by balancing blood sugar, lipids, and blood clotting.
Participation in CHINA BIO, BIO PHAMA AMERICA and BIO EUROPE
11/8/2020
GN Corporation has been selected for JETRO’s participation support program and attends digital exhibitions.
Press Release
New Advances in Regenerative Treatments for Cartilage Injuries Published in THE KNEE
11/3/2021
GNC succeeded in culturing hyaluronic acid-rich chondrocytes in a 3D
The Potential of Nichi Glucan as a Vaccine Adjuvant
7/3/2021
A paper describing the potentials of Nichi Glucan as Vaccine
India’s Kasturba University team wins the 15th Fujio Cup Quiz
10/10/2020
India’s Kasturba Medical College team won the 15th…